RASMutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers
Author(s) -
Nikhil Gupta,
Anil K. Dasyam,
Sally E. Carty,
Mari. Nikiforova,
N. Paul Ohori,
Michaele J. Armstrong,
Linwah Yip,
Shane O. LeBeau,
Kelly L. McCoy,
Christopher J. Coyne,
Michael T. Stang,
Jonas T. Johnson,
Robert L. Ferris,
Raja R. Seethala,
Yuri E. Nikiforov,
Steven P. Hodak
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-3396
Subject(s) - medicine , thyroid cancer , pathology , thyroid , thyroglobulin , follicular thyroid cancer , papillary thyroid cancer , cancer , lymph node , medullary thyroid cancer , thyroidectomy , thyroid nodules , medullary cavity , histology
RAS mutations are common in thyroid tumors and confer a high risk of cancer when detected in fine-needle aspiration (FNA) specimens. Specific characteristics of RAS-positive thyroid cancers are not well described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom